CT-732

N/A

Report date: 2023/01/14 21:03:11
NME

Base Information

Drug NameCT-732
Drug Alias NameCT-732
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase delta inhibitors
TargetsPhosphatidylinositol 3 kinase delta
Therapy Area/IndicationsSolid tumoursArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHec Pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHec Pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A